TB- PRACTECAL: A randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug resistant tuberculosis.

Principal investigator

Bern-Thomas Nyang'wa
Purpose of study
Purpose of study

Identify regimens containing bedaquiline and pretomanid for further evaluation based on safety and efficacy outcomes after 8 weeks of treatment. And to evaluate the safety and efficacy of the investigational regimens containing bedaquiline and pre...

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline

Documents

Publications

  • Principles for designing future regimens for multidrug-resistant tuberculosis
    Brigden, Grania "–" WHO Press "(2013)"
  • Resistance to second-line drugs in multidrug-resistant tuberculosis
    Nyang'wa, Bern-Thomas "–" Elsevier BV "(2013)"
Previous study
Next study